Reduce Sedentary Time in Acute Lymphoblastic Leukemia

Completed · Not applicable

Conditions studied: Acute Lymphoblastic Leukemia (ALL)

In brief

The goal of this feasibility trial is to test if a mobile health intervention, including a wearable fitness tracker with inactivity-triggered reminders to move, individualized coaching sessions, and an app-based peer support group, can decrease sedentary time (time spent sitting/lying down and inactive) in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy. The main questions it aims to answer are: * Is the intervention a feasible and acceptable way to decrease sedentary time among adolescents and young adults (AYAs) with ALL? * Does the intervention show evidence that it may decrease sedentary time? * Does the intervention show evidence that it may increase quality of life, reduce inflammation, and improve glucose and lipid metabolism? Participants will use their fitness tracker with reminders to move as well as support from other intervention participants and coaching with study staff to gradually decrease their sedentary time over 10 weeks. Researchers will compare participant pre- and post-intervention study measures to see if the program may be helpful to decrease sedentary time in adolescents and young adults (AYAs) with ALL. All participants will wear an activity tracker on the thigh for 7 days at the beginning and end of the study as well as complete quality of life questionnaires. Study labs will be collected three times (baseline, 8 weeks, and 12 weeks) over the course of the 12-week study. All in-person study visits and labs will occur in conjunction with Oncology clinic visits for maintenance chemotherapy.

Key facts

Study ID

NCT06182163

Run by

Children's Hospital Los Angeles

People needed

20

Starts

2024-07-01

Expected to finish

2025-12-17

Last updated by the study team

2026-07-07

Who can join

Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 12-21 years of age at time of enrollment
• Diagnosis of lymphoblastic leukemia/lymphoma treated with Children's Oncology Group (COG)-based maintenance chemotherapy [B-cell acute lymphoblastic leukemia/lymphoma (B-ALL/Ly), T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/Ly), mixed phenotype acute leukemia (MPAL)]
• Has completed at least one month of maintenance chemotherapy and has at least one cycle (3 months) remaining.
• Baseline sedentary lifestyle with a self-reported average of 4 or more leisure-time hours per day spent sedentary (verbal report)
• Willing to reduce their sedentary time
• Parent/legal guardian available for consent (if applicable), and patient available for assent or consent as applicable
• Has access to internet and smartphone compatible with Fitbit and WhatsApp (own or parent/legal guardian's)
• Ability to participate in virtual sessions with study staff
• Fluent in English (Parent/legal guardian does not need to be fluent in English as long as they can provide consent, if needed, in their primary language)

You may not qualify if…

• Evidence of recurrent or metastatic disease
• Inability to obtain consent/assent
• Medical contraindication to daily standing and light physical activity [>1.5 metabolic equivalents of task (METs)]
• Intellectual disability or developmental delay which limits ability to fully participate in the study intervention
• Unable to obtain laboratory studies
• Unable to accurately perform quality of life surveys independently
• Unable to complete study-related surveys
• Pregnancy or current imprisonment

Where it is running

• Children's Hospital Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.